Cite
HARVARD Citation
Tian, D. et al. (2022). 23-hydroxybetulinic acid reduces tumorigenesis, metastasis and immunosuppression in a mouse model of hepatocellular carcinoma via disruption of the MAPK signaling pathway. Anti-cancer drugs. 33 (9), pp. 815-825. [Online].